Literature DB >> 25802109

Psychometric evaluation of the negative syndrome of schizophrenia.

Maria Paz Garcia-Portilla1,2, Leticia Garcia-Alvarez2, Pilar A Saiz1,2, Susana Al-Halabi2, Maria Teresa Bobes-Bascaran3, Maria Teresa Bascaran2, José Muñiz2,4, Julio Bobes5,6.   

Abstract

In this paper, we reviewed the available instruments for assessing the negative syndrome of schizophrenia, describing their strengths and weaknesses. Current instruments were classified into two categories according to their content validity and assessment approach as first- or second-generation instruments. The BPRS, SANS, the SENS and the PANSS belong to the first generation, while the BNSS, the CAINS and the MAP-SR belong to the second generation. The NSA can be considered a transitional instrument between the two. First-generation instruments have more content validity problems than second-generation instruments do, as they do not accurately reflect the currently accepted negative syndrome (they do not include all negative symptoms and signs or they include symptoms from other dimensions). They also have more problems relative to the use of behavioural referents instead of internal experiences of deficits when assessing symptoms, which may lead to measuring functioning instead of negative symptoms. Further research needs to be done in this area in order to ensure the evaluation of primary negative symptoms and internal experiences involved in negative symptoms rather than external behaviours.

Entities:  

Keywords:  Negative syndrome; Patient outcomes; Psychometric evaluation; Schizophrenia

Mesh:

Year:  2015        PMID: 25802109     DOI: 10.1007/s00406-015-0595-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

1.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

2.  The new challenge in identifying the negative syndrome of schizophrenia.

Authors:  M Paz García-Portilla; Julio Bobes
Journal:  Rev Psiquiatr Salud Ment       Date:  2013 Oct-Dec       Impact factor: 3.318

3.  Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E).

Authors:  P M Dingemans; D H Linszen; M E Lenior; R M Smeets
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.

Authors:  L D Alphs; A Summerfelt; H Lann; R J Muller
Journal:  Psychopharmacol Bull       Date:  1989

5.  The CAINS: theoretical and practical advances in the assessment of negative symptoms in schizophrenia.

Authors:  Deanna M Barch
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

6.  Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

Authors:  Stephanie G Park; Katiah Llerena; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Schizophr Res       Date:  2012-01-21       Impact factor: 4.939

Review 7.  Is the PANSS used correctly? a systematic review.

Authors:  Michael Obermeier; Rebecca Schennach-Wolff; Sebastian Meyer; Hans-Jürgen Möller; Michael Riedel; Daniela Krause; Florian Seemüller
Journal:  BMC Psychiatry       Date:  2011-07-18       Impact factor: 3.630

8.  The subjective experience of negative symptoms: a self-rating scale.

Authors:  J P Selten; N E Sijben; R J van den Bosch; J Omloo-Visser; H Warmerdam
Journal:  Compr Psychiatry       Date:  1993 May-Jun       Impact factor: 3.735

9.  Symptom monitoring in the rehabilitation of schizophrenic patients.

Authors:  D Lukoff; R P Liberman; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

10.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

View more
  16 in total

1.  Negative symptoms and therapy strategies in schizophrenia.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10       Impact factor: 5.270

2.  Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial.

Authors:  Leandro da Costa Lane Valiengo; Stephan Goerigk; Pedro Caldana Gordon; Frank Padberg; Mauricio Henriques Serpa; Stephanie Koebe; Leonardo Afonso Dos Santos; Roger Alberto Marcos Lovera; Juliana Barbosa de Carvalho; Martinus van de Bilt; Acioly L T Lacerda; Helio Elkis; Wagner Farid Gattaz; Andre R Brunoni
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

Review 3.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

Review 4.  Understanding Antipsychotic Drug Treatment Effects: A Novel Method to Reduce Pseudospecificity of the Positive and Negative Syndrome Scale (PANSS) Factors.

Authors:  Seth C Hopkins; Ajay Ogirala; Antony Loebel; Kenneth S Koblan
Journal:  Innov Clin Neurosci       Date:  2017-12-01

Review 5.  Pharmacological treatment of negative symptoms in schizophrenia.

Authors:  Hans-Jürgen Möller; Pal Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-04-21       Impact factor: 5.270

6.  Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial.

Authors:  Samantha V Abram; Lize De Coster; Brian J Roach; Bryon A Mueller; Theo G M van Erp; Vince D Calhoun; Adrian Preda; Kelvin O Lim; Jessica A Turner; Judith M Ford; Daniel H Mathalon; Joshua D Woolley
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

7.  Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Ian M Raugh; Luyu Zhang; Lauren Luther; Hannah C Chapman; Daniel N Allen; Brian Kirkpatrick; Alex S Cohen
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-15

8.  Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms.

Authors:  Seon-Kyeong Jang; Seon-Cheol Park; Kee-Hong Choi; Jung-Seo Yi; Joong-Kyu Park; Jung Suk Lee; Seung-Hwan Lee
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

9.  An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).

Authors:  Suneeta Kumari; Mansoor Malik; Christina Florival; Partam Manalai; Snezana Sonje
Journal:  J Addict Res Ther       Date:  2017-05-11

10.  Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With Schizophrenia.

Authors:  Seth C Hopkins; Ajay Ogirala; Antony Loebel; Kenneth S Koblan
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.